Literature DB >> 10588612

Eotaxin and impaired lung function in asthma.

H Nakamura1, S T Weiss, E Israel, A D Luster, J M Drazen, C M Lilly.   

Abstract

We performed an association study of plasma eotaxin levels, eosinophil counts, total IgE levels, asthma diagnosis, and lung function in an ethnically diverse and geographically dispersed population. We studied 515 asthmatic and 519 normal subjects, none of whom was taking inhaled or oral corticosteroids. Logistic regression analysis demonstrated a direct relationship between asthma diagnosis and eotaxin levels (p < 0.0001). The odds of an asthma diagnosis increased with eotaxin quartile, with the highest quartile having an odds ratio of 5.4 (95% CI 3.2 to 9.2, p < 0.001) compared with the lowest eotaxin quartile. Eotaxin levels were inversely related to lung function (p < 0.001), with the mean percent predicted FEV(1) in the highest eotaxin quartile being 13.5 percentage points (SEM 2.1, p < 0.001) less than that in the lowest quartile. Plasma eotaxin levels were associated with asthma and inversely related to lung function independent of age, race, sex, or smoking status. When combined with eosinophil counts and IgE levels, eotaxin levels contributed to the odds of an asthma diagnosis and of impaired lung function. Our results are the first to associate eotaxin levels with asthma diagnosis and compromised lung function in a large geographically and ethnically diverse population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588612     DOI: 10.1164/ajrccm.160.6.9811089

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  Chemokines in allergic lung inflammation.

Authors:  Clare Lloyd
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.

Authors:  Alison E John; Molly S Thomas; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

3.  A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels.

Authors:  Jyotsna Batra; Reenu Rajpoot; Jasmine Ahluwalia; Satish K Devarapu; Surendra K Sharma; Amit K Dinda; Balaram Ghosh
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

Review 4.  Obesity and asthma.

Authors:  David A Beuther; Scott T Weiss; E Rand Sutherland
Journal:  Am J Respir Crit Care Med       Date:  2006-04-20       Impact factor: 21.405

Review 5.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

6.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness.

Authors:  Alison A Humbles; Bao Lu; Daniel S Friend; Shoji Okinaga; Jose Lora; Amal Al-Garawi; Thomas R Martin; Norma P Gerard; Craig Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

7.  IL-13 Gene Polymorphisms are Associated With Rhinosinusitis and Eosinophilic Inflammation in Aspirin Intolerant Asthma.

Authors:  Nami Shrestha Palikhe; Seung-Hyun Kim; Bo-Young Cho; Gil-Soon Choi; Joo-Hee Kim; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

8.  Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Authors:  Ziemowit Zietkowski; Maria M Tomasiak-Lozowska; Roman Skiepko; Elzbieta Zietkowska; Anna Bodzenta-Lukaszyk
Journal:  Respir Res       Date:  2010-08-12

9.  Immune-Associated Proteins Are Enriched in Lung Tissue-Derived Extracellular Vesicles during Allergen-Induced Eosinophilic Airway Inflammation.

Authors:  Cecilia Lässer; Yasunari Kishino; Kyong-Su Park; Ganesh Vilas Shelke; Nasibeh Karimi; Shintaro Suzuki; Lilit Hovhannisyan; Madeleine Rådinger; Jan Lötvall
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

10.  IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.

Authors:  Arzu D Yalcin; Atil Bisgin; Reginald M Gorczynski
Journal:  Mediators Inflamm       Date:  2012-12-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.